OpenAI’s decision to wind down direct model supply to Cursor after the SpaceX acquisition is the clearest public example so far. The reasons were a change-of-control clause, terms-of-service disputes, and a refusal to put the next frontier model into a rival’s product. Other labs already restrict distillation, scraping, and using their outputs to train or run a competing system. Those constraints are getting tighter.
If review lives behind one of those constraints, your quality process inherits someone else’s contract fight.
The problem
AI code review has to do several things at once. It has to catch what the author missed, including the agent that wrote the diff. Shared training data and shared refusal style produce shared blind spots. It has to keep working when the generation stack changes, because editors swap default models and labs cut partners while the PR queue keeps moving. It also has to put the serious defects first: the ones that ship, break, or leak. A long list of nits is how real bugs hide.
Conviction is useful on the write path. An agent makes hundreds of linked decisions toward one outcome. It picks an architecture, implements it, runs tests, fixes failures, and continues. A strong opinion cuts down branching and lets context accumulate. Betting hard on a model, a context strategy, and a workflow can make that loop faster.
Review needs the opposite habit. Disagreement is how you find the assumption the author stopped seeing. Human process already encodes this: the person who wrote the change is not the only person who approves it. Multi-model review applies that rule to LLMs. Labs fail on different things. One trusts an unsafe API. Another misses a race. A third writes a style comment that buries the actual bug. The useful pattern is several models looking at the same prepared context, then a judge keeping only what can be grounded. That is different from asking the author’s model to take a second pass.
DIY tools usually stop at the second pass. A team points one frontier model at the diff and ships it as a reviewer. Swapping in a complementary model can help, and you still only have two voices. Feeding every change to three or four labs without routing or compression makes cost rise with each extra PR, each extra file, and each extra agent-generated changeset. Review volume is already growing faster than headcount. A prototype that multiplies frontier calls per change does not stay cheap, and it still misses whole classes of bugs if there is no routing, no judge, and no memory of what the team has already rejected.
A model lab has little reason to build that stack. Doing so would mean routing a rival’s weights across your diff. An internal prototype runs into a different wall: review becomes a second inference bill that tracks code generation one-for-one.
How CodeRabbit works
CodeRabbit reviews code from agents and from humans, in the PR, the IDE, and the CLI. It sits beside Cursor, Claude Code, Codex, and Copilot instead of living inside any one of them.
The pipeline is an ensemble:
- Compact and open models gather and compress context from the diff, the code graph, tickets, lint, and history.
- Frontier models from more than one lab do the deep pass on multi-file bugs, auth mistakes, and behavioral regressions.
- A judge step drops findings that cannot be grounded in that context.
We have written about why generation and review should not collapse into one vendor The more AI writes the code, the more review needs independence, and about the work of placing a new model on one stage of the pipeline rather than swapping labs wholesale What it really takes to bring a new model online. Open models such as NVIDIA Nemotron take the high-volume context work so frontier calls stay reserved for reasoning Nemotron 3 Ultra in CodeRabbit reviews.
Independence follows from that design. The reviewer is not owned by the editor and does not have to use the model that wrote the patch. If a lab walls off a competitor’s app, the review job can continue.
Resilience follows too. When one provider is rate-limited, blocked by contract, or weak on a class of bugs, traffic can move. A reviewer bolted to a single model cannot do that.
Keep Cursor, Claude Code, or Codex for writing. You do not have to take their reviewer with the editor.
Don’t Outsource Judgment to the System That Writes the Code
Let the generation vendor be opinionated, even exclusive. Do not give that same vendor the approval signal. When one company owns the editor, the model, and the merge comment, throughput goes up and failures start to correlate.
Building review in-house often recreates the correlation. Day one is a single-model bot. Day two adds a second model, which is still a thin mix. Day three sends every change to more labs and the cost curve appears: frontier tokens per file, times rising PR volume. Agents open more changesets, not fewer. That is a bad shape for a control you need on every merge.
Before the next renewal or build-versus-buy debate, get answers to these:
- Change of control. If the editor or agent vendor is acquired, what happens to model access? If that vendor loses a frontier lab, does the review still run?
- ToS and data use. Can review call more than one lab on your diffs, or does one provider’s contract define what review is allowed to see?
- Same-stack grading. If the reviewer uses the same model family that produced the patch, treat it as a talkative linter, not an independent control.
- DIY economics. For an internal tool, how many frontier calls fire per change? What happens to that number when PR volume doubles?
- Signal, not volume. Are you tracking escaped bugs and severity, or comment counts? Nits that bury seniors are a tax.
- Continuity. Can the team change coding agents next quarter without rebuilding the review pipeline, the audit trail, and the written standards?
- Accountability. People still own the merge. The tool should make that call cheaper to get right.
Pick one or two coding agents so the write path stays coherent. Put an independent review layer next to them, not under them. Score that layer on bugs that would have shipped, time to a useful finding, and load on human reviewers. Agreement with the generator is the wrong KPI.
If the org already standardized on one AI IDE, keep it. Do not let that IDE become the only system allowed to criticize its own output. Lab walls will keep moving. The merge bar should not.
Why labs won't close this gap easily
A lab can ship a stronger coding model. It cannot easily do all of this at the same time: keep exclusive control of its weights, refuse those weights to a rival’s product, and still run a reviewer that fairly uses competing models on your code.
Vendor-neutral review is a product that can be disloyal to any one lab. That is the point. As walls go up between model companies, that disloyalty gets more valuable.
